期刊文献+

环吡酮胺治疗复发性外阴阴道念珠菌病的疗效 被引量:4

下载PDF
导出
摘要 目的:探讨环吡酮胺阴道乳膏治疗复发性外阴阴道念珠菌病(recurrent vulvovaginal candidiasis,RVVC)的效果。方法:选择2011年1月至2012年1月在本院妇科门诊就诊的RVVC患者71例,随机分为两组,其中观察组37例,对照组34例。观察组环吡酮胺软膏阴道给药,5g/d,连用7d;对照组硝酸咪康唑栓阴道给药,200mg/d,连用7d。比较两组临床应用效果。结果:(1)用药24h内症状缓解率:观察组和对照组分别为70.27%(26/37)和44.12%(15/34),两组比较差异有统计学意义(P<0.05)。(2)停药后1周总有效率:观察组为94.59%,对照组为82.35%,两组比较差异无统计学意义(P>0.05)。(3)观察组在停药后的1、3、6个月有显著降低复发率,分别为0%、0%、5.71%,而对照组停药后的1、3、6个月复发率分别为17.85%、25.00%、46.42%,两组比较差异有统计学意义(P<0.05、P<0.01、P<0.01)。结论:吡酮胺阴道乳膏治疗RVVC的疗效明显,且能显著降低复发率,优于传统治疗药物硝酸咪康唑栓。
出处 《实用医学杂志》 CAS 北大核心 2012年第24期4164-4165,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献6

二级参考文献27

  • 1中华妇产科学分会感染性疾病协作组.外阴阴道念珠菌病诊治规范(草案)[J].中华妇产科杂志,2004,39(6):430-431. 被引量:490
  • 2郑华生.1%环吡酮胺软膏治疗浅部真菌病的疗效观察[J].岭南皮肤性病科杂志,2004,11(3):236-237. 被引量:3
  • 3陈兴平,陈映玲,万沐芬,王慧君.水合肼作用后红色毛癣菌的超微结构观察[J].中华皮肤科杂志,1996,29(5):358-359. 被引量:2
  • 4Rad MM,Zafarghandi S,Abbasabadi B,et al.The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population[J].Eur J Obstet Gynecol Reprod Biol,2011,155(2):199-203.
  • 5Spinillo A,Colonna L,Piazzi G,et al.Managing recurrent vulvovaginal candidiasis:intermittent prevention with itraconazole[J].J Reprod Med,1997,42(2):83-87.
  • 6Frieden TR,Jaffe HW,Stephens JW,et al.Centers for Disease Control and Prevention.Diseases characterized by Vaginal Discharge[J].MMWR,2010,59:1-116.
  • 7Barone JA,Moskovitz BL,Guarnieri J,et al.Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers[J].Antimicrob Agents Chemother,1998,42(7):1862-1865.
  • 8Fong IW.The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis[J].Genitourin Med,1992,68(6):374-377.
  • 9Witt A,Kaufmann U,Bitschnau M,et al.Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal candidiasis:a randomised trial[J].BJOG,2009,116(11):1499-1505.
  • 10Casalinuovo IA,Di Francesco P,Garaci E.Fluconazole resistance in Candida albicans:a review of mechanisms[J].Eur Rev Med Pharmacol Sci,2004,8(2):69-77.

共引文献32

同被引文献31

  • 1中华妇产科学分会感染性疾病协作组.外阴阴道念珠菌病诊治规范(草案)[J].中华妇产科杂志,2004,39(6):430-431. 被引量:490
  • 2谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 3Ono F,Yasumoto S.Genital candidiasis[J].Nippon Rinsho,2009,67(1):157-161.
  • 4Clinical and Laboratory Standards Institute.Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard.http://www.clsi.org/source/orders/free/M27-A3.pdf.Published 2008.
  • 5Subissi A,Monti D,Togni G,et al.Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent[J].Drugs,2010,70(16): 2133-2152.
  • 6丽秀,黄丹维,李静.康妇消炎栓配合克霉唑阴道泡腾片治疗复发性外阴阴道念珠菌病44例临床分析.中外健康文摘,2013,10(7):42,43.
  • 7Rad MM, Zafarghandi S, Abbasabadi B, e! al. The epidemiology ofCandida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J obstet Gynecol ReprcM Biot ,201 i, 155 (2) : 199 - 203.
  • 8Frieden TR,Jaffe HW,stephens JW,et al. Centers fi:r disease control and prevention. Diseases characterized by vaginal discharge. MMWR, 2010(59) :ll - 16.
  • 9Mikamo H, Matsumizu M, Nakazuru Y, Okayama A, Nagashima M. Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginalcandicliasis in Japan[J]. J Infect Chemother, 2015,21 : 520-526.
  • 10Workowski K A, Berman SI Centers for Disease Control and Prevention (CI)C). Sexually transmitted diseases treatment guidelines, 2010 [J]. MMWR Recomm Rep, 2010,59(RR-12) : 1-110.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部